Studies on human blood platelets in affective disorder.

Area of Science:

• Neuroscience
• Biochemistry
• Psychiatry

Background:

• Affective disorders, including depression, are complex mental health conditions.
• Indolylamine and electrolyte metabolism play roles in mood regulation.
• Previous research indicated altered peripheral cell enzyme activity in depression.

Purpose of the Study:

• To investigate platelet indolylamine and electrolyte metabolism in patients with affective disorder.
• To examine the impact of lithium therapy on platelet parameters.
• To determine if peripheral cell membrane enzyme changes are consistent across different cell types in affective disorder.

Main Methods:

• Assessed platelet membrane ATPase and adenyl cyclase specific activity.
• Measured the 5-hydroxy-tryptamine (serotonin) uptake process kinetics (Vmax, Km) in platelets.
• Compared patient groups (unipolar and bipolar depression) with control subjects.
• Evaluated the effect of lithium therapy on platelet parameters.

Main Results:

• No significant differences in platelet membrane ATPase or adenyl cyclase activity were found between patients and controls.
• A reduced Vmax and y for serotonin uptake into platelets was observed in both unipolar and bipolar depressed groups.
• Platelet serotonin uptake Km did not differ significantly between patient groups and controls.
• Lithium therapy did not significantly influence any examined platelet parameters.

Conclusions:

• Altered serotonin uptake kinetics in platelets are present in unipolar and bipolar depression.
• The observed platelet changes do not appear to be a universal feature of all peripheral cells in affective disorder.
• Findings suggest that peripheral cell membrane enzyme alterations may not consistently reflect central nervous system changes in affective disorder.